Day One Biopharmaceuticals

Day One Biopharmaceuticals

Day One Biopharmaceuticals

We are a new biotech company focused on developing new cancer therapies for patients of all ages.
Raised
$60M
Follow us
Alexa global traffic share
22 May 2020
$60,000,000
Venture capital (Series A)
Canaan Partners, Atlas Venture, Access Biotechnology

Cancer Drugmaker Day One Biopharmaceuticals Launches With $60 Million

WSJ Venture Capital
+1